← Leaderboards
Robert William Doebler
Claremont Biosolutions, Llc
$1,252,640
Attributed
$5,243,263
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2012–17$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,243,263 · 2
By mechanism
R44$3,000,000 · 1
R01$2,243,263 · 1
Top collaborators
- Angelika Niemz7 shared
- Gerard A Cangelosi4 shared
- Masa Narita4 shared
- David Scott Boyle3 shared
- Tanya Marie Ferguson2 shared
- Brenda Elaine Jones2 shared
- Bruce D Irvine1 shared
Most similar at Claremont Biosolutions, Llc
Same institution · by research overlap
- Bruce D Irvine$859,306
- Tanya Marie Ferguson$500,000
Others in their field
Top investigators on “Training”
- Jeffrey P Krischer · University Of South Florida$314,856,919
- Christopher McKay · Battelle Memorial Institute$290,340,771
- Judith S. Currier · University Of California Los Angeles$276,624,848
- Daniel R Kuritzkes · Brigham And Women'S Hospital$258,658,543
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$239,830,683
- Steven E Reis · University Of Pittsburgh At Pittsburgh$232,330,444
Research focus
TrainingSamplingPreparationSputumDevicesCostMonitorPoint Of CareResearch PersonnelSensitivity And SpecificityDesignDetectionDiagnosticDiagnosisDna AmplificationInstrumentBaseMycobacterium TuberculosisCytolysisReagentCross-PrimingAwardDiagnostic ProcedureBiothreat
Grant awards (7)
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$538,394
R01 · FY2017 · AI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$541,354
R01 · FY2016 · AI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$555,804
R01 · FY2015 · AI
A fully integrated assay and platform for detecting Clostridium difficile.$1,000,000
R44 · FY2014 · AI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$607,711
R01 · FY2014 · AI
A fully integrated assay and platform for detecting Clostridium difficile.$1,000,000
R44 · FY2013 · AI
A fully integrated assay and platform for detecting Clostridium difficile.$1,000,000
R44 · FY2012 · AI